• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Prudential Jennison Health Sciences Fund

+ Add to Watchlist

PHLBX:US

33.00 USD 0.06 0.18%

As of 09:29:30 ET on 04/15/2014.

Snapshot for Prudential Jennison Health Sciences Fund (PHLBX)

Year To Date: -4.60% 3-Month: -11.91% 3-Year: +22.36% 52-Week Range: 26.39 - 41.52
1-Month: -16.48% 1-Year: +21.99% 5-Year: +26.89% Beta vs SPR: 0.96

Mutual Fund Chart for PHLBX

No chart data available.
  • PHLBX:US 33.00
  • 1M
  • 1Y
Interactive PHLBX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for PHLBX

Prudential Jennison Health Sciences Fund is an open-end fund incorporated in the USA. The Fund's objective is long-term capital appreciation. The Fund invests at least 80% of assets plus borrowings for investment purposes in securities of companies in the health sciences sector, such as pharmaceutical, biotechnology and healthcare service providers.

Inception Date: 06-30-1999 Telephone: 1-800-225-1852
Managers: DAVID CHAN / MICHAEL DEL BALSO
Web Site: www.prudentialfunds.com

Fundamentals for PHLBX

NAV (on 2014-04-15) 33.00
Assets (M) (on 2014-02-28) 2,690.37
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 100.00

Dividends for PHLBX

Dividend Type Short Term Cap Gain
Dividend Frequency Semi-Anl
Last Dividend Net (on 2013-12-17) 0.54
Dividend Yield (ttm) 9.79

Fees & Expenses for PHLBX

Front Load 0.00
Back Load 5.00
Current Mgmt Fee 0.73
Redemption Fee 0.00
12b1 Fee 1.00
Expense Ratio 1.88

Top Fund Holdings for PHLBX

Filing Date: 02/28/2014
Name Position Value % of Total
BioMarin Pharmaceutical Inc 1,752,708 141,969,348 5.177%
Alexion Pharmaceuticals Inc 713,145 126,084,036 4.598%
Vertex Pharmaceuticals Inc 1,436,140 116,126,280 4.235%
Intercept Pharmaceuticals Inc 257,681 105,778,051 3.857%
Incyte Corp Ltd 1,607,959 103,327,445 3.768%
Roche Holding AG 287,488 88,517,595 3.228%
Biogen Idec Inc 246,945 84,129,223 3.068%
Celldex Therapeutics Inc 2,637,771 77,075,669 2.811%
Isis Pharmaceuticals Inc 1,444,868 73,688,268 2.687%
HCA Holdings Inc 1,356,472 69,451,366 2.533%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil